Operating Lease, Weighted Average Discount Rate, Percent of Protalix BioTherapeutics, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
Protalix BioTherapeutics, Inc. quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Protalix BioTherapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending 31 Dec 2025 was 0.134, a 4.7% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Change (%)

Protalix BioTherapeutics, Inc. Quarterly Operating Lease, Weighted Average Discount Rate, Percent (pure)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 0.134 +0.006 +4.7% 31 Dec 2025 10-K 18 Mar 2026 2025 FY
Q3 2025 0.134 +0.006 +4.7% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q4 2024 0.128 0 0% 31 Dec 2024 10-K 18 Mar 2026 2025 FY
Q3 2024 0.128 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q4 2023 0.128 0 0% 31 Dec 2023 10-K 18 Mar 2026 2025 FY
Q4 2022 0.128 0 0% 31 Dec 2022 10-K 17 Mar 2025 2024 FY
Q4 2021 0.128 +0.001 +0.79% 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q4 2020 0.127 0 0% 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q4 2019 0.127 31 Dec 2019 10-K 31 Mar 2022 2021 FY
Q3 2019 0.1255 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 0.1258 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 0.1258 31 Mar 2019 10-Q 06 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.